214 related articles for article (PubMed ID: 1405756)
1. Beneficial effects of post-transfusional hepatitis in acute myelogenous leukemia may be mediated by lipopolysaccharides, tumor necrosis factor alpha and interferon gamma.
Treon SP; Broitman SA
Leukemia; 1992 Oct; 6(10):1036-42. PubMed ID: 1405756
[TBL] [Abstract][Full Text] [Related]
2. Growth restraint and differentiation by LPS/TNF-alpha/IFN-gamma reorganization of the microtubule network in human leukemia cell lines.
Treon SP; Anand B; Chou IN; Broitman SA
Leukemia; 1992; 6 Suppl 3():141S-145S. PubMed ID: 1602811
[TBL] [Abstract][Full Text] [Related]
3. CD14 mediated endogenous TNF-alpha release in HL60 AML cells: a potential model for CD14 mediated endogenous cytokine release in the treatment of AML.
Treon SP; Anand B; Ulevitch R; Broitman SA
Leuk Res; 1994 Jan; 18(1):17-21. PubMed ID: 7507190
[TBL] [Abstract][Full Text] [Related]
4. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
5. Maturation-dependent susceptibility to monocyte-mediated cytotoxicity in acute myeloid leukemia.
van de Loosdrecht AA; Ossenkoppele GJ; Beelen RH; Broekhoven MG; van Hooff MH; Dräger AM; Huijgens PC; Langenhuijsen MM
Leukemia; 1994 Aug; 8(8):1392-400. PubMed ID: 8057679
[TBL] [Abstract][Full Text] [Related]
6. Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia.
Geissler K; Tricot G; Leemhuis T; Walker E; Broxmeyer HE
Cancer Res; 1989 Jun; 49(11):3057-62. PubMed ID: 2497971
[TBL] [Abstract][Full Text] [Related]
7. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
8. Polar agents with differentiation-inducing capacity prime myelomonocytic cell lines to lipopolysaccharide-induced cytolysis: the role of endogenous tumor necrosis factor.
Depraetere S; Joniau M
Leukemia; 1994 Nov; 8(11):1951-9. PubMed ID: 7967741
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
[TBL] [Abstract][Full Text] [Related]
10. Effects of transforming growth factor beta, tumor necrosis factor alpha, interferon gamma and LIF-HILDA on the proliferation of acute myeloid leukemia cells.
Kerangueven F; Sempere C; Tabilio A; Mannoni P
Eur Cytokine Netw; 1990; 1(2):99-107. PubMed ID: 2129395
[TBL] [Abstract][Full Text] [Related]
11. IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes.
Joyce DA; Steer JH
Cytokine; 1996 Jan; 8(1):49-57. PubMed ID: 8742066
[TBL] [Abstract][Full Text] [Related]
12. Biochemical events accompanying macrophage activation and the inhibition of colony-stimulating factor-1-induced macrophage proliferation by tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide.
Vairo G; Royston AK; Hamilton JA
J Cell Physiol; 1992 Jun; 151(3):630-41. PubMed ID: 1338337
[TBL] [Abstract][Full Text] [Related]
13. The modulation of IL-6 and TNF-alpha release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma.
Deakin AM; Payne AN; Whittle BJ; Moncada S
Cytokine; 1995 Jul; 7(5):408-16. PubMed ID: 7578978
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.
Marchant A; Bruyns C; Vandenabeele P; Ducarme M; Gérard C; Delvaux A; De Groote D; Abramowicz D; Velu T; Goldman M
Eur J Immunol; 1994 May; 24(5):1167-71. PubMed ID: 8181527
[TBL] [Abstract][Full Text] [Related]
15. Differentiation-inducing and cytotoxic effects of tumor necrosis factor and interferon-gamma in myeloblastic ML-1 cells.
Craig RW; Buchan HL
J Cell Physiol; 1989 Oct; 141(1):46-52. PubMed ID: 2506196
[TBL] [Abstract][Full Text] [Related]
16. [The role of TNF-alpha in the growth and differentiation of U937 cells induced by PMA and IFN-gamma].
Wu J; Wang ML; Xu Z; Qiu SL; Zhu JQ; Zhu DX
Shi Yan Sheng Wu Xue Bao; 1994 Sep; 27(3):307-13. PubMed ID: 7801724
[TBL] [Abstract][Full Text] [Related]
17. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines.
Kamijo R; Takeda K; Nagumo M; Konno K
J Immunol; 1990 Feb; 144(4):1311-6. PubMed ID: 2105994
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming.
Szefler SJ; Norton CE; Ball B; Gross JM; Aida Y; Pabst MJ
J Immunol; 1989 Jun; 142(11):3985-92. PubMed ID: 2541203
[TBL] [Abstract][Full Text] [Related]
19. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
[TBL] [Abstract][Full Text] [Related]
20. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA
J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
